{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:06:31Z","timestamp":1789632391809,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05179-0","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T02:00:27Z","timestamp":1778032827000},"page":"4139-4146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Value of PSA density in PI-RADS 3 lesions: a single-center retrospective observational study"],"prefix":"10.1007","volume":"58","author":[{"given":"Patricia","family":"Rodriguez-Parras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zambudio-Munuera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Donaire-Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaiza","family":"Ya\u00f1ez-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"del Carmen Cano-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Arrabal-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Arrabal-Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"10071","key":"5179_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, Collaco-Moraes Y, Ward K, Hindley RG, Freeman A, Kirkham AP, Oldroyd R, Parker C, Emberton M, PROMIS study group (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815\u2013822. https:\/\/doi.org\/10.1016\/S0140-6736(16)32401-1","journal-title":"Lancet"},{"key":"5179_CR2","unstructured":"European Association of Urology. EAU Guidelines on Prostate Cancer 2024\u20132025. Arnhem (The Netherlands): European Association of Urology Guidelines Office;. Available from: https:\/\/uroweb.org\/guidelines\/prostate-cancer"},{"issue":"3","key":"5179_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, Tempany CM, Choyke PL, Cornud F, Margolis DJ, Thoeny HC, Verma S, Barentsz J, Weinreb JC (2019) Prostate Imaging Reporting and Data System Version 2.1: 2019 update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 76(3):340\u2013351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033","journal-title":"Eur Urol"},{"issue":"4","key":"5179_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.eururo.2014.10.050","volume":"67","author":"IG Schoots","year":"2015","unstructured":"Schoots IG, Petrides N, Giganti F, Bokhorst LP, Rannikko A, Klotz L, Villers A, Hugosson J, Moore CM (2015) Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review. Eur Urol 67(4):627\u2013636. https:\/\/doi.org\/10.1016\/j.eururo.2014.10.050","journal-title":"Eur Urol"},{"issue":"11","key":"5179_CR5","doi-asserted-by":"publisher","first-page":"490.e1","DOI":"10.1016\/j.urolonc.2022.08.003","volume":"40","author":"J Drevik","year":"2022","unstructured":"Drevik J, Dalimov Z, Uzzo R, Danella J, Guzzo T, Belkoff L, Raman J, Tomaszewski J, Trabulsi E, Reese A, Singer EA, Syed K, Jacobs B, Correa A, Smaldone M, Ginzburg S (2022) Utility of PSA density in patients with PI-RADS 3 lesions across a large multi-institutional collaborative. Urol Oncol 40(11):490.e1-490.e6. https:\/\/doi.org\/10.1016\/j.urolonc.2022.08.003","journal-title":"Urol Oncol"},{"issue":"3 Pt 2","key":"5179_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/s0022-5347(17)37393-7","volume":"147","author":"MC Benson","year":"1992","unstructured":"Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, Cooner WH (1992) Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 147(3 Pt 2):815\u2013816. https:\/\/doi.org\/10.1016\/s0022-5347(17)37393-7","journal-title":"J Urol"},{"issue":"2","key":"5179_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.euo.2023.08.002","volume":"7","author":"S Wang","year":"2024","unstructured":"Wang S, Kozarek J, Russell R, Drescher M, Khan A, Kundra V, Barry KH, Naslund M, Siddiqui MM (2024) Diagnostic performance of prostate-specific antigen density for detecting clinically significant prostate cancer in the era of magnetic resonance imaging: a systematic review and meta-analysis. Eur Urol Oncol 7(2):189\u2013203. https:\/\/doi.org\/10.1016\/j.euo.2023.08.002","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"5179_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4274\/uob.galenos.2023.2023.6.2","volume":"23","author":"A Aslano\u011flu","year":"2024","unstructured":"Aslano\u011flu A, Sayg\u0131n H, \u00d6zt\u00fcrk A, Ergin \u0130E, Asdemir A, Velibeyo\u011flu AF (2024) Correlation between PSA density and multiparametric prostate MRI in the diagnosis of prostate cancer. Bull Urooncology 23(1):29\u201335. https:\/\/doi.org\/10.4274\/uob.galenos.2023.2023.6.2","journal-title":"Bull Urooncology"},{"key":"5179_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2023.05.005","author":"TA Nguyen","year":"2023","unstructured":"Nguyen TA, Fourcade A, Zambon A et al (2023) Optimal PSA density threshold and predictive factors for the detection of clinically significant prostate cancer in patients with a PI-RADS 3 lesion on MRI. Urol Oncol. https:\/\/doi.org\/10.1016\/j.urolonc.2023.05.005","journal-title":"Urol Oncol"},{"issue":"2","key":"5179_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bju.15277","volume":"127","author":"IG Schoots","year":"2021","unstructured":"Schoots IG, Padhani AR (2021) Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation. BJU Int 127(2):175\u2013178. https:\/\/doi.org\/10.1111\/bju.15277","journal-title":"BJU Int"},{"issue":"4","key":"5179_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4067\/S0717-93082019000400119","volume":"25","author":"MF Tapia","year":"2019","unstructured":"Tapia MF, Labra W, Adlerstein I, Olivares JP, Schultz M, Silva C, Pinochet R, Orvieto M (2019) Densidad de APE en pacientes PI-RADS 3: un par\u00e1metro cl\u00ednico \u00fatil para su manejo. Rev Chil Radiol 25(4):119\u2013127. https:\/\/doi.org\/10.4067\/S0717-93082019000400119","journal-title":"Rev Chil Radiol"},{"issue":"10","key":"5179_CR12","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, STROBE Initiative (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4(10):e296. https:\/\/doi.org\/10.1371\/journal.pmed.0040296","journal-title":"PLoS Med"},{"issue":"2","key":"5179_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4081\/aiua.2021.2.139","volume":"93","author":"P Pepe","year":"2021","unstructured":"Pepe P, Candiano G, Pepe L, Pennisi M, Fraggetta F (2021) mpMRI PI-RADS score 3 lesions diagnosed by reference vs affiliated radiological centers: our experience in 950 cases. Arch Ital Urol Androl 93(2):139\u2013142. https:\/\/doi.org\/10.4081\/aiua.2021.2.139","journal-title":"Arch Ital Urol Androl"},{"issue":"253","key":"5179_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/01621459.1951.10500769","volume":"46","author":"FJ Massey Jr","year":"1951","unstructured":"Massey FJ Jr (1951) The Kolmogorov-Smirnov test for goodness of fit. J Am Stat Assoc 46(253):68\u201378. https:\/\/doi.org\/10.1080\/01621459.1951.10500769","journal-title":"J Am Stat Assoc"},{"issue":"11","key":"5179_CR15","doi-asserted-by":"publisher","first-page":"e96432","DOI":"10.7759\/cureus.96432","volume":"17","author":"MA Nazir","year":"2025","unstructured":"Nazir MA, Scobie M, Balasubaramaniam V et al (2025) Evaluating prostate-specific antigen (PSA) density thresholds for detecting clinically significant prostate cancer in Prostate Imaging Reporting and Data System (PI-RADS) 3 lesions: a retrospective cohort study. Cureus 17(11):e96432. https:\/\/doi.org\/10.7759\/cureus.96432","journal-title":"Cureus"},{"issue":"1","key":"5179_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12894-025-01986-2","volume":"25","author":"T Franz","year":"2025","unstructured":"Franz T, Sicker T, Lueke J, Dinh B, Ho TP, Spinos T et al (2025) To biopsy or not biopsy, that is the question\u2014PI-RADS 3 prostate lesions: validation of clinical and radiological parameters for biopsy decision-making. BMC Urol 25(1):274. https:\/\/doi.org\/10.1186\/s12894-025-01986-2","journal-title":"BMC Urol"},{"key":"5179_CR17","doi-asserted-by":"publisher","first-page":"1602412","DOI":"10.3389\/fonc.2025.1602412","volume":"15","author":"Y Li","year":"2025","unstructured":"Li Y, Wang S, Wang J, Qi X, Liu T, He X (2025) PI-RADSv2.1 combined with PSA density for optimizing prostate biopsy decisions: a retrospective analysis. Front Oncol 15:1602412. https:\/\/doi.org\/10.3389\/fonc.2025.1602412","journal-title":"Front Oncol"},{"issue":"4","key":"5179_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/pcan.2010.29","volume":"13","author":"P Pepe","year":"2010","unstructured":"Pepe P, Aragona F (2010) Incidence of insignificant prostate cancer using free\/total PSA: results of a case-finding protocol on 14,453 patients. Prostate Cancer Prostatic Dis 13(4):316\u2013319. https:\/\/doi.org\/10.1038\/pcan.2010.29","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"5179_CR19","doi-asserted-by":"publisher","first-page":"11322","DOI":"10.4081\/aiua.2023.11322","volume":"95","author":"P Pepe","year":"2023","unstructured":"Pepe P, Pepe L, Tamburo M, Marletta G, Savoca F, Pennisi M, Fraggetta F (2023) 68Ga-PSMA PET\/CT evaluation in men enrolled in prostate cancer active surveillance. Arch Ital Urol Androl 95(2):11322. https:\/\/doi.org\/10.4081\/aiua.2023.11322","journal-title":"Arch Ital Urol Androl"},{"issue":"3","key":"5179_CR20","doi-asserted-by":"publisher","first-page":"e244258","DOI":"10.1001\/jamanetworkopen.2024.4258","volume":"7","author":"A Haj-Mirzaian","year":"2024","unstructured":"Haj-Mirzaian A, Burk KS, Lacson R et al (2024) Magnetic resonance imaging, clinical, and biopsy findings in suspected prostate cancer: a systematic review and meta-analysis. JAMA Netw Open 7(3):e244258. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.4258","journal-title":"JAMA Netw Open"},{"issue":"1153","key":"5179_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/bjr\/tqad027","volume":"97","author":"I Rajendran","year":"2024","unstructured":"Rajendran I, Lee KL, Thavaraja L, Barrett T (2024) Risk stratification of prostate cancer with MRI and prostate-specific antigen density-based tool for personalized decision making. Br J Radiol 97(1153):113\u2013119. https:\/\/doi.org\/10.1093\/bjr\/tqad027","journal-title":"Br J Radiol"},{"key":"5179_CR22","doi-asserted-by":"publisher","first-page":"32830","DOI":"10.1038\/s41598-025-18336-9","volume":"15","author":"C Wang","year":"2025","unstructured":"Wang C, Han J, Zhu W et al (2025) A nomogram using transition zone PSA density for detecting clinically significant prostate cancer in PI-RADS 3 lesions. Sci Rep 15:32830. https:\/\/doi.org\/10.1038\/s41598-025-18336-9","journal-title":"Sci Rep"},{"issue":"11","key":"5179_CR23","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.3390\/curroncol31110503","volume":"31","author":"LJ Jensen","year":"2024","unstructured":"Jensen LJ, Kim D, Elgeti T, Steffen IG, Schaafs LA, Haas M et al (2024) Detecting clinically significant prostate cancer in PI-RADS 3 lesions using T2w-derived radiomics feature maps in 3T prostate MRI. Curr Oncol 31(11):6814\u20136828. https:\/\/doi.org\/10.3390\/curroncol31110503","journal-title":"Curr Oncol"},{"key":"5179_CR24","doi-asserted-by":"publisher","DOI":"10.4274\/dir.2025.253590","author":"S Aslan","year":"2025","unstructured":"Aslan S, S\u00fcl\u00fcn E, \u00c7ak\u0131r E, O\u011fuz U, Bek\u00e7i T (2025) Diagnostic performance of magnetic resonance imaging-targeted biopsy for PI-RADS \u22653 peripheral zone lesions in multiparametric prostate magnetic resonance imaging: correlation with clinically significant prostate cancer. Diagn Interv Radiol. https:\/\/doi.org\/10.4274\/dir.2025.253590","journal-title":"Diagn Interv Radiol"},{"key":"5179_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-025-12272-y","author":"S Durmaz","year":"2026","unstructured":"Durmaz S, Wu SCJ, Lee KL et al (2026) The effects of prostate volume and PI-RADS category on optimal PSA-density thresholds for biopsy decision-making. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-025-12272-y","journal-title":"Eur Radiol"},{"key":"5179_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.prnil.2025.12.006","author":"J Song","year":"2026","unstructured":"Song J, Park J, Ahn H, Hwang SI, Lee HJ, Chung Y et al (2026) Risk stratification for repeat prostate biopsy: PI-RADS 3 lesions and the differential role of PSA density. Prostate Int. https:\/\/doi.org\/10.1016\/j.prnil.2025.12.006","journal-title":"Prostate Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05179-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:53:24Z","timestamp":1789631604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05179-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5179"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05179-0","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"5 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Research Ethics Committee of Hospital Universitario Cl\u00ednico San Cecilio (Granada, Spain) (approval code: PHIRM1). Given its retrospective observational nature, individual informed consent was waived. The study was conducted in accordance with the Declaration of Helsinki and current European data protection legislation (EU Regulation 2016\/679).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study design, analysis, and reporting were conducted in accordance with the STROBE recommendations for observational studies.","order":3,"name":"Ethics","label":"STROBE compliance","group":{"name":"EthicsHeading","label":"Declarations"}}]}}